This Growth Stock Surged 758% in 2024. Here's Why 2025 Could Bring More Massive Gains. — Positive
APP 24/7 Wall Street — February 11, 2025AppLovin (NASDAQ:APP) is a mobile app publisher and developer of AI-driven monetization tools that's seen a strong rebound over the past year, as investors piled into companies that have the ability to accelerate ad spending and adoption.

Rackspace Technology Scales Digital Capabilities and Enhances Customer Experiences for Dealer eProcess on Google Cloud — Neutral
RXT GlobeNewsWire — February 11, 2025Leading automotive digital agency now supports dealership websites by managing millions of visitors monthly with a modernized cloud infrastructure Leading automotive digital agency now supports dealership websites by managing millions of visitors monthly with a modernized cloud infrastructure

4 Pollution Control Stocks to Watch Despite Industry Headwinds — Negative
CECO DCI ERII FTEK Zacks Investment Research — February 11, 2025Despite the high adoption of air pollution control equipment, the growing preference for alternative fuels and the high costs of innovation are limiting the prospects for the Zacks Pollution Control industry. DCI, CECO, ERII and FTEK are four stocks to consider.

AI chip startup Positron raises $23.5 million seed round to take on Nvidia — Positive
NVDA Reuters — February 11, 2025Positron, a startup chip maker that aims to compete with Nvidia , said Tuesday it raised $23.5 million to scale production of its U.S.-made artificial intelligence chips.

Compass Minerals International (CMP -4.12%), a leader in salt and specialty plant nutrition production, delivered a mixed report for its fiscal 2025 first quarter on Feb. 10. The company's non-GAAP loss of $0.55 per share contrasted with the earnings per share (EPS) of $0.13 anticipated by analysts.

Lost Money on Pliant Therapeutics, Inc. (PLRX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation — Neutral
PLRX Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX) concerning possible violations of federal securities laws. On February 7, 2025, Pliant announced that following a prespecified data review and recommendations by the trial's independent Data Safety Monitoring Board, it had voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.

3 Chip Stocks Still Trading 50% Below Their 52-Week Highs — Neutral
AMD INTC SMCI MarketBeat — February 11, 2025The semiconductor industry has become an intense area of focus in the stock market over the past few years. It's always been important, but the advent of artificial intelligence is driving unprecedented interest.

Boeing says it delivered 45 aircraft in busiest January since 2023 — Positive
BA Reuters — February 11, 2025Boeing said on Tuesday that it had delivered 45 airplanes in January, up from 30 deliveries the previous month and the most deliveries in a month for the U.S. planemaker since 2023.

MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart — Neutral
MET Seeking Alpha — February 11, 2025MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart

Deere & Company's stock is currently expensive with a high forward P/E of 24, but investor optimism is driven by an expected gradual recovery through 2025. Deere's earnings report is crucial, especially regarding inventory management and production hours, as competitors face significant declines and market downturns. Despite a weak 2025 outlook, Deere's strong market position and technology in precision agriculture and autonomous solutions offer long-term potential.

With $20K to invest, debating between Super Micro Computer and Intel—what's the smarter move? — Positive
INTC SMCI 24/7 Wall Street — February 11, 2025“The Next NVIDIA” Could Change Your Life NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.

Analysts Estimate Genuine Parts (GPC) to Report a Decline in Earnings: What to Look Out for — Negative
GPC Zacks Investment Research — February 11, 2025Genuine Parts (GPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Flowserve (FLS) Earnings Expected to Grow: Should You Buy? — Positive
FLS Zacks Investment Research — February 11, 2025Flowserve (FLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Magnolia Oil & Gas Corp (MGY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release — Positive
MGY Zacks Investment Research — February 11, 2025Magnolia Oil & Gas Corp (MGY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Occidental Petroleum (OXY) Q4 Earnings Expected to Decline — Negative
OXY Zacks Investment Research — February 11, 2025Occidental (OXY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

International Flavors (IFF) Earnings Expected to Grow: Should You Buy? — Positive
IFF Zacks Investment Research — February 11, 2025International Flavors (IFF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Valmont Industries (VMI) Earnings Expected to Grow: Should You Buy? — Neutral
VMI Zacks Investment Research — February 11, 2025Valmont (VMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sonoco (SON) Earnings Expected to Grow: Should You Buy? — Neutral
SON Zacks Investment Research — February 11, 2025Sonoco (SON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Watsco (WSO) Earnings Expected to Grow: Should You Buy? — Positive
WSO Zacks Investment Research — February 11, 2025Watsco (WSO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Allegion (ALLE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral
ALLE Zacks Investment Research — February 11, 2025Allegion (ALLE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
